Dare Bioscience (DARE) Equity Average (2016 - 2025)
Historic Equity Average for Dare Bioscience (DARE) over the last 10 years, with Q3 2025 value amounting to -$4.9 million.
- Dare Bioscience's Equity Average fell 93194.32% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year decrease of 93194.32%. This contributed to the annual value of -$5.5 million for FY2024, which is 28236.93% down from last year.
- Latest data reveals that Dare Bioscience reported Equity Average of -$4.9 million as of Q3 2025, which was down 93194.32% from -$11.1 million recorded in Q2 2025.
- In the past 5 years, Dare Bioscience's Equity Average ranged from a high of $35.3 million in Q4 2021 and a low of -$11.1 million during Q2 2025
- In the last 5 years, Dare Bioscience's Equity Average had a median value of $1.1 million in 2021 and averaged $7.4 million.
- Per our database at Business Quant, Dare Bioscience's Equity Average skyrocketed by 378801.21% in 2021 and then crashed by 93194.32% in 2025.
- Dare Bioscience's Equity Average (Quarter) stood at $35.3 million in 2021, then plummeted by 46.98% to $18.7 million in 2022, then crashed by 119.59% to -$3.7 million in 2023, then dropped by 2.18% to -$3.7 million in 2024, then tumbled by 31.73% to -$4.9 million in 2025.
- Its Equity Average was -$4.9 million in Q3 2025, compared to -$11.1 million in Q2 2025 and -$7.8 million in Q1 2025.